In partnership with the Broad Institute of MIT and Harvard, and the Laboratory for Molecular Medicine (LMM) at Partners HealthCare Personalized Medicine, we are one of three Genome Centers/Clinical Validation Laboratories for All of Us. Color is responsible for variant detection and interpretation as an initial step for the return of health-related genetic information to one million or more people living in the United States. Color is also the sole All of Us Genetic Counseling Resource.

In collaboration with the University of California system and the Sanford Health system — one of the most rural health networks in the country — we are the exclusive genomic testing provider for Women Informed to Screen Depending on Measures of risk (WISDOM). WISDOM ​is a 5-year, randomized control trial of 100,000 women aged 40-74 that compares annual screening with a personalized, risk-based breast cancer screening schedule.

Verily and Color are partnering to return actionable genetic information to all participants of Project Baseline. Participants will have access to Color’s physician-ordered, clinical-grade genomic services, board certified genetic counselors, and clinical pharmacists, enabling them to better understand their risk for certain hereditary cancers, heart disease, and medication response.

We are working with researchers at the Fred Hutchinson Cancer Research Center and the University of Washington to increase access to genetic testing and counseling to all men with advanced prostate cancer as part of the GENTleMEN study. With Color’s support, the GENTleMEN Study has expanded across the US, removing barriers to genetic services. This work is supported by the Color Foundation and the Institute for Prostate Cancer Research.

We are working with researchers at Fox Chase Center of Temple University Health System and the University of the West Indies, School of Clinical Medicine and Research to determine the frequency and spectrum of pathogenic variants in men with metastatic prostate cancer from the Bahamas. The goal is to collect samples from approximately 100 men as a pilot to determine the feasibility of a larger study.